A hepatitis C virus NS4B inhibitor suppresses viral genome replication by disrupting NS4B's dimerization/multimerization as well as its interaction with NS5A. (Q39381557)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A hepatitis C virus NS4B inhibitor suppresses viral genome replication by disrupting NS4B's dimerization/multimerization as well as its interaction with NS5A.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A hepatitis C virus NS4B inhibitor suppresses viral genome replication by disrupting NS4B's dimerization/multimerization as well as its interaction with NS5A. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Moonju Choi

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sungjin Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Taekyu Choi

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Choongho Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

19 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

395-407

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

https://scigraph.springernature.com/pub.10.1007/s11262-013-0956-5

0 references

Global epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

The results of Phase III clinical trials with telaprevir and boceprevir presented at the Liver Meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

A second hepatitis C virus-encoded proteinase

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein.

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Topology of the Membrane-Associated Hepatitis C Virus Protein NS4B

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Identification of a Novel Determinant for Membrane Association in Hepatitis C Virus Nonstructural Protein 4B

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Amphipathic alpha-helix AH2 is a major determinant for the oligomerization of hepatitis C virus nonstructural protein 4B

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

A small molecule inhibits HCV replication and alters NS4B's subcellular distribution.

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

A Rab-GAP TBC domain protein binds hepatitis C virus NS5A and mediates viral replication

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Interaction of hepatitis C virus core protein with janus kinase is required for efficient production of infectious viruses

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Mechanisms shaping the membranes of cellular organelles

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

The reticulon and DP1/Yop1p proteins form immobile oligomers in the tubular endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Palmitoylation and Polymerization of Hepatitis C Virus NS4B Protein

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Karyoplasmic interaction selection strategy: a general strategy to detect protein-protein interactions in mammalian cells

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Roles of phosphoinositides and phosphoinositides kinases in hepatitis C virus RNA replication

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

Dimerization of the hepatitis C virus nonstructural protein 4B depends on the integrity of an aminoterminal basic leucine zipper

1 reference

https://api.crossref.org/works/10.1007%2FS11262-013-0956-5

21 January 2018

NS5A: a new target for antiviral drugs in the treatment of hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868571

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and identification of hepatitis C virus polyprotein cleavage products

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868571

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of hepatitis C: its impact on clinical management

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868571

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868571

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868571

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a class of HCV inhibitors directed against the nonstructural protein NS4B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868571

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868571

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11262-013-0956-5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

release_5w2j6mfvznf6vjugdnvqo633ta

1 reference

https://api.fatcat.wiki/v0/release/5w2j6mfvznf6vjugdnvqo633ta

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39381557&oldid=1835450317"